| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 695788 | N(sup .alpha.)-[4-[(2,4-Diamino-5-methylpyrido[2,3-d] pyrimidin-6-yl)methyl]amino]benzoyl-n(sup .delta.)-hemiphthaloyl-L-ornithine | 0.0219024304994664 | 0.035753715 |
| NSC 725099 | Null | 0.0219024304994664 | 0.25654501 |
| NSC 731700 | 1[(4-benzyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-dio late | 0.0219024304994664 | 0.2040452 |
| NSC 756169 | GSK317314A | 0.024108502230778 | 0.22034456 |
| NSC 123463 | Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) | 0.0241085022307781 | 0.23231238 |
| NSC 220334 | Replaced CAS registry number(s): 66835-31-2 | 0.0241085022307781 | 0.47536535 |
| NSC 301739 | Mitoxantrone | 0.0241085022307781 | 0.074590707 |
| NSC 311152 | 6H-Pyrido[4,3-b]carbazolium, 2-[2-(diethylamino)ethyl]-9-hydroxy-5,11-dimethyl-, acetate (salt) (9CI) | 0.0241085022307781 | -0.026521195 |
| NSC 617989 | 3-Deazaneplanocin, hydrochloride | 0.0241085022307781 | 0.26624463 |
| NSC 625817 | Null | 0.0241085022307781 | 0.32946697 |